| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |